Evolution of the cancer genome.

Trends in Genetics : TIG
Ondrej PodlahaFranziska Michor

Abstract

Human tumors result from an evolutionary process operating on somatic cells within tissues, whereby natural selection operates on the phenotypic variability generated by the accumulation of genetic, genomic and epigenetic alterations. This somatic evolution leads to adaptations such as increased proliferative, angiogenic, and invasive phenotypes. In this review we outline how cancer genomes are beginning to be investigated from an evolutionary perspective. We describe recent progress in the cataloging of somatic genetic and genomic alterations, and investigate the contributions of germline as well as epigenetic factors to cancer genome evolution. Finally, we outline the challenges facing researchers who investigate the processes driving the evolution of the cancer genome.

References

Oct 1, 1976·Science·P C Nowell
Jul 1, 1986·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·P J Fitzgerald
Sep 27, 1995·International Journal of Cancer. Journal International Du Cancer·M R TeixeiraS Heim
Nov 18, 1993·Nature·S J Gould, N Eldredge
Sep 17, 1998·Nature·R Z ChenR Jaenisch
Jan 1, 1999·Nature·C LengauerB Vogelstein
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Nov 2, 2001·Nature·T ReyaI L Weissman
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Apr 19, 2003·Science·François GaudetRudolf Jaenisch
Mar 1, 1958·Nature·J C FISHER
Jan 6, 2004·Genetics·Pamela E Bennett-BakerDavid T Burke
Jul 21, 2004·Trends in Genetics : TIG·Hans T BjornssonAndrew P Feinberg
Dec 20, 2005·Gynecologic Oncology·Jing Wang ChiangRae Lynn Baldwin
Dec 22, 2005·Nature Reviews. Genetics·Andrew P FeinbergSteven Henikoff
Feb 24, 2006·Nature Reviews. Cancer·Stephen B Baylin, Joyce E Ohm
Mar 28, 2006·Nature Genetics·Carlo C MaleyBrian J Reid
May 12, 2006·Journal of Cellular Physiology·Henry H Q HengChristine J Ye
Aug 8, 2006·Nature Medicine·Larry Norton, Joan Massagué
Aug 25, 2006·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Kansei KomakiAkira Tangoku
Sep 9, 2006·Science·Tobias SjöblomVictor E Velculescu
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Barbara BachtiaryFei-Fei Liu
Feb 27, 2007·Cell·Peter A Jones, Stephen B Baylin
Mar 9, 2007·Nature·Christopher GreenmanMichael R Stratton
Jun 2, 2007·Science·David S JohnsonBarbara Wold
Jun 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Piero DalerbaMichael F Clarke
Dec 14, 2007·Proceedings of the National Academy of Sciences of the United States of America·Rameen BeroukhimWilliam R Sellers
Dec 29, 2007·Nature Genetics·Michael R Stratton, Nazneen Rahman
Apr 23, 2008·Current Protocols in Human Genetics·S A ForbesM R Stratton
Jul 5, 2008·Nature·Alexander MeissnerEric S Lander
Sep 6, 2008·Nature·UNKNOWN Cancer Genome Atlas Research Network
Feb 25, 2009·Cancer Science·Minoru ToyotaYasuhisa Shinomura
Mar 17, 2009·Nature Genetics·Amy V JonesNicholas C P Cross
Mar 17, 2009·Nature Genetics·Damla OlcayduRobert Kralovics
Apr 8, 2009·Nature Methods·Fuchou TangM Azim Surani
Nov 12, 2009·Genome Research·Nicholas NavinMichael Wigler

❮ Previous
Next ❯

Citations

Jul 31, 2013·Nucleic Acids Research·Francesco StrinoYuval Kluger
Jun 2, 2014·Molecular Biology and Evolution·Feixiong ChengZhongming Zhao
Aug 22, 2014·Proceedings. Biological Sciences·Yoav Ram, Lilach Hadany
Oct 9, 2014·Systematic Biology·Niko BeerenwinkelFlorian Markowetz
Apr 6, 2013·Biomedical Microdevices·Peter DelNeroClaudia Fischbach
Mar 27, 2013·The Journal of Cell Biology·Rebekka A SchwabWojciech Niedzwiedz
Sep 26, 2013·Expert Review of Molecular Diagnostics·Konradin Metze
Jan 15, 2013·Gastroenterology·Virginia Hernandez-GeaJosep M Llovet
Nov 13, 2012·Experimental and Molecular Pathology·Ashley G Rivenbark, William B Coleman
Aug 27, 2014·Genome Biology·Yijun SunSteve Goodison
Mar 18, 2015·Cancer Biology & Therapy·Varun V Prabhu, Wafik S El-Deiry
Apr 19, 2012·Cell Cycle·Richard F Wooster
Mar 15, 2015·PLoS Genetics·Li ChenJaved Khan
Dec 3, 2014·Fertility and Sterility·Franck PellestorGeneviève Lefort
Jun 13, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michail IgnatiadisJean-Yves Pierga
Apr 2, 2015·Biochimica Et Biophysica Acta·Samra TurajlicCharles Swanton
Sep 1, 2015·Computers in Biology and Medicine·Michał Krześlak, Andrzej Świerniak
Sep 10, 2015·IEEE/ACM Transactions on Computational Biology and Bioinformatics·Daniele CatanzaroRussell Schwartz
Jul 8, 2015·The Lancet Oncology·Siddhartha DevarakondaRamaswamy Govindan
Oct 2, 2013·The Lancet Oncology·Malcolm K BrennerJuan F Vera
Jun 28, 2016·Comptes rendus biologies·Nina HabermannJan O Korbel
Jul 28, 2015·Cell Reports·Ashley M LaughneySamuel F Bakhoum
Dec 19, 2014·British Journal of Haematology·Susann WeißbachEllen Leich
Jul 16, 2016·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Beata UjvariKatherine Belov
Feb 14, 2017·Nature Reviews. Genetics·Russell Schwartz, Alejandro A Schäffer
Jul 9, 2014·PLoS Biology·Mariam Jamal-HanjaniCharles Swanton
Feb 6, 2016·PLoS Computational Biology·Niko BeerenwinkelJens Lagergren
Oct 13, 2015·International Journal of Cancer. Journal International Du Cancer·Agata RodeAurélie Ernst

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Nature
Mel F Greaves, Carlo C Maley
Nature Reviews. Cancer
Andriy MarusykKornelia Polyak
Nature
Michael R StrattonP Andrew Futreal
© 2022 Meta ULC. All rights reserved